Events Partner Content TCR-based Therapeutics for Solid Tumors Summit Hear from experts at the TCR based Therapeutics Summit
Events Partner Content Multi-Functional Cell Therapies Summit Development with Next-Generation Cell Therapies
News Disappointment for BMS as Zeposia fails Crohn’s study Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.